FDA approves Humira for AS

The FDA has approved Humira (adalimumab) for the treatment of ankylosing spondylitis, its manufacturer, Abbott Laboratories, reported today. See previous entries: Humira approved for AS in Europe; Humira (adalimumab) and AS: clinical trials.

Update, Aug. 4: Lots of coverage on the financial nets, some on the wire services, but this story from the Worcester Telegram and Gazette is better than most.